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Uterine fibroids or leiomyomas are the most common benign female genital tumors, although this pathology can 
also manifest itself outside the uterus, as in the case we present, with a retroperitoneal development. In this article, 
authors showed a rare case of 81-year-old women, with a right pelvic mass and lower abdominal discomfort. Basing 
on a preoperative radiological imaging, clinicians oriented to a provisional diagnosis of mesenchymal neoplasm of 
an uncertain origin. During surgery in the retroperitoneal space, it was detected a huge mass close to the uterus, 
beneath the right broad ligament. After the opening of the retroperitoneal spaces, surgeons enucleated a well-
demarcated tumor, measuring 12 x 7 cm in diameter and histopathological findings demonstrated a rare retroper-
itoneal uterine leiomyoma. 
 





Uterine fibroids or leiomyomas are the most 
common benign gynecological tumors, usually 
originating and included in the uterus. This is 
one of the most common female diseases and 
one of the most common cause of hysterecto-
mies (Sparic et al. 2016). Generally, the retroper-
itoneal origin of a fibroid is very unusual.  
Retroperitoneal fibroid has a marked morpho-
logic similarity to uterine leiomyoma, by virtue 
of hyaline change end trabecular pattern of 
growth (Yüksel et al. 2020) 
Nevertheless, a tumor in this retroperitoneal re-
gion with a leiomyomatosic appearance, has a 
differential diagnosis with a uterine leiomyoma 
extending posteriorly, a well-differentiated leio-
myosarcoma, benign and a malignant gastroin-
testinal stromal tumor (GIST) (Barnaś et al. 
2019). 
This differential diagnosis can lead to make the 
misdiagnosis, or challenge the strategy of treat-
ment of tumor, shifting towards very invasive 
and radical treatments. 
 
2. Case presentation  
 
We report the case of an 81-year-old woman, 
hospitalized for diagnostic investigation after in-
cidental finding of a pelvic mass on ultrasonog-
raphy and a successive computerized tomogra-
phy (CT) imaging scan, assessing the presence of 
a wide solid mass of size 12 x 7 cm in the pelvic 
cavity. 
At radiological appearance, this mass showed 
regular boundary, with isolated intralesional cal-
cifications, inhomogeneous vascularity and hy-
podense areas peripherally. A CT guided mass 
biopsy was performed, with 3 samples of size 5 
mm each. Those samples showed stromal frus-
tules immunoreactive for smooth muscle actin 
(SMA) and negative for S-100 protein, 
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CKAE1/AE3 and CD34 so they were made of 
smooth muscle. 
Thus, the entire mass was surgically enucleated 
in laparotomy and transported to the pathologi-
cal anatomy unit for complete histological eval-
uation. 
The morphological findings of the enucleated 
mass showed an irregular shape, with a compact, 
swirling and whitish cut surface (Figure 1). He-
matoxylin and eosin staining revealed the inter-
secting fascicles of spindle cells (Figure 2), with 
no necrosis and mitotic activity. The immuno-
histochemical staining was positive for SMA and 
desmin (Figure 3) and negative for S-100 protein 
and CD117 (C-Kit). Therefore, the definitive di-
agnosis was a rare case of retroperitoneal fi-
broids or leiomyoma. 
The patient’ postoperative course was unevent-
ful, with a discharging after seven days after sur-
gery. No several adverse events occurred. Pa-
tients follow up showed no evidence of recur-
rent retroperitoneal leiomyoma, until now. 
 
 
Figure 1. Grossly, it is well circumscribed mass, and the surface 
shows white whirling appearance. 
 
 
Figure 2. The tumor consists of intersecting fascicles of spin-
dle cells (H & E, x100). 
 
Figure 3. Immunohistochemical stain for desmin revealed posi-





This clinical report represents a rare case of ret-
roperitoneal leiomyoma, which has a hard pre-
operative diagnosis, by radiological imaging. A 
complete surgical removal is necessary for 
pathological diagnosis and treatment (Mahendru 
et al. 2012).  
Uterine fibroids are the most common gyneco-
logical benign tumors, accounting up to 25% of 
the reproductive aged women, usually involving 
uterine body, but they may occur in any site of 
the uterus (Sparic et al. 2016).  
They have an unusual growth pattern and the in-
cidence among primary retroperitoneal tumors 
has been reported as very low rate up to 1.2% 
(Naykı et al. 2014), located in the pelvis in the 
73% of cases (Poliquin, Victory, and Vilos 2008). 
Retroperitoneal tumor is a rare condition, and 
the incidence of malignant retroperitoneal tu-
mors is higher than benign tumors (Tantitamit et 
al. 2015). Dalen et al. (Dalen et al. 2001) reported 
that the incidence of malignant retroperitoneal 
tumors was 80% of all primary non-visceral tu-
mors in the retroperitoneum and sarcomas such 
as liposarcoma or leiomyosarcoma comprised 
one third of retroperitoneal malignant tumors. 
 
Several theories of the pathogenesis of extrauter-
ine leiomyoma including retroperitoneal leiomy-
oma were suggested as followed: benign metas-
tasizing leiomyoma, disseminated peritoneal 
leiomyomatosis, intravenous dissemination, par-
asitic leiomyoma, and so on (Barnaś et al. 2019). 
Of these theories, "parasitic" leiomyoma was 
first described by Kelly and Cullen (Howard At-
wood and Cullen 1909) and it was defined as 
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completely separation of the pedunculated leio-
myoma from uterus, with receiving their blood 
supply from another source.  
Recently, as the increasing morcellation during 
myomectomy or hysterectomy, the theory of 
"iatrogenic" parasitic leiomyoma was suggested, 
as tumor growing by the fibroids’ seeding during 
morcellation (Mynbaev et al. 2017).  
Anyway, retroperitoneal parasitic leiomyoma is 
very rare condition. There are few reports of 
"parasitic myoma" and almost of these litera-
tures are just case reports or small series.  
Kho and Nezhat reported 12 cases of parasitic 
myoma in a single institution for 8 years. Of 12 
cases of parasitic myoma, only 2 cases were 
found retroperitoneal space in this report (Kho 
and Nezhat 2009).  
After a huge multidisciplinary clinical discussion 
on its origin, we thought that our reported case 
of retroperitoneal fibroid was consistent with a 
parasitic leiomyoma, since it had a separate 
blood supply, neither from uterine artery nor 
from ovarian artery. But patient had no evidence 
of concurrently uterine leiomyoma or no history 
of remote hysterectomy for fibroids or myomec-
tomy, so the possibility of "iatrogenic" parasitic 
leiomyoma was clinically rejected.  
Preoperative diagnosis of retroperitoneal leio-
myoma can be very changeling, because of the 
rarity of this tumor. Common symptoms of ret-
roperitoneal fibroids include abdominal discom-
fort, fatigue, backache, dyspareunia, and urinary 
and bowel complaints (Poliquin, Victory, and Vi-
los 2008). 
About radiological preoperative diagnosis, pelvic 
magnetic resonance imaging (MRI) with contrast 
medium, is the most reliable technique for eval-
uating a retroperitoneal leiomyoma and for as-
sess the anatomical location. But it could be dif-
ficult to differentiate a leiomyoma from a leio-
myosarcoma basing on radiological imaging, 
such as pelvic CT scan or pelvic MRI alone (Kar-
ray et al. 2018). Some features of these retroper-
itoneal masses show an extensive central necro-
sis, invasive growth pattern, and heterogeneous 
appearance. They are helpful to differentiate a 
leiomyosarcoma from a leiomyoma (Mynbaev et 
al. 2020). In the literature there are cases diag-
nosed with fine needle aspiration biopsy [(DUR-
SUN et al. 2005). The use of preoperative anti-
gens, particularly Ca 125 and carcinoembryionic 
antigens, could be useful in patients with large 
tumors; in literature a case of CA-125 was re-
ported to be high in leiomyomas 15 cm and 
above (Bischof et al. 1992).  
Anyway, histomorphologic diagnosis is always 
mandatory for such cases, so as it is mandatory 
to preoperatively diagnose the retroperitoneal 
tumor as accurately as possible, since it can lead 
to an appropriate surgical method to remove the 
mass, as the problem is how to proceed, whether 
to radically remove the mass in laparotomy or to 
remove only the fibroid in laparoscopy (Tinelli 
and Farghaly 2018; Kondo et al. 2011). Moreo-
ver, preoperative radiological assessment of tu-
mor vascularization is also necessary.  
Surgery seems to be the only valid therapeutic 
option. Particularly, open surgery was the most 
used strategy in many reported cases. Large tu-
mor size at the moment of diagnosis could be a 
contraindication to laparoscopic or robotic ap-
proach. Kondo (Tinelli and Farghaly 2018) re-
ported a case of retroperitoneal fibroid where re-
section was done by laparoscopic approach. Age 
of the woman influences the therapeutic ap-
proach (hysterectomy vs leiomyoma resection). 
Ultrasonography-guided or CT-guided fine-nee-
dle aspiration or biopsy may be histologically 
beneficial for the expectant management of 
asymptomatic patients refusing operation 
(Yüksel et al. 2020; L. Max et al. 2017).  
Regular follow-up is mandatory because malig-
nant transformation cannot be excluded (Jeong 
2014; Paal and Miettinen 2001), but the progno-




The retroperitoneal uterine fibroid or leiomy-
oma is a rare condition, very difficult to diagnose 
preoperatively. This difficulty obviously also re-
flects on the surgical methodology to be applied 
in the removal: laparotomic radicality or mini-
mally invasive surgery in case of fibroid (Billings, 
Folpe, and Weiss 2001). 
A careful preoperative analysis of radiological 
imaging scan, by CT and MRI, or by intraopera-
tive surgical and histological findings at frozen 
sections, may be helpful to diagnose accurately 
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